March 07, 2011

Sanofi-aventis Extends Offer for all Outstanding Shares of Genzyme

 

Sanofi-aventis Extends Offer for all Outstanding Shares of Genzyme

Paris, France – 8 March 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today it had signed a new agreement to donate $25 million, extending its decade-long partnership with the World Health Organization (WHO) for another five years to control neglected tropical diseases, including the potentially fatal Human African Trypanosomiasis, also known as sleeping sickness. The agreement was signed today by Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, and Dr. Margaret Chan, WHO Director- General, at WHO headquarters in Geneva, Switzerland.